When opioids fail in chronic pain management: The role for buprenorphine and hospitalization

American Journal of Therapeutics

Volumn 20, Issue 4, 2013, Pages 316-321

  Berland, Daniel W ^a   Malinoff, Herbert L ^b   Weiner, Mark A ^c   Przybylski, Robert ^a  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c ST JOSEPH MERCY HOSPITAL   (United States)

Author keywords

Buprenorphine; Chronic pain; Hospitalization; Management; Opioids; Outcomes; Toxicity

Indexed keywords

BUPRENORPHINE; MORPHINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANALGESIA; ANXIETY DISORDER; ARTICLE; BONE MARROW TRANSPLANTATION; BORDERLINE STATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIAPHORESIS; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SICKLE CELL ANEMIA; SLEEP DISORDERED BREATHING;

EID: 84880823783     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31827ab599     Document Type: Article

References (25)

1. Kelly JP. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138:507-513.
2. Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA. 2012;307:1377-1378.
3. Noble M, Tregear SJ, Treadwell JR, et al. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35:214-228.
4. Seehusen DA. Cochrane for clinicians: opioid therapy for chronic noncancer pain. Am Fam Physician. 2010;82:40.
5. Meier B. Pain pills add cost and delays to job injuries. New York Times. June 2, 2012. http://www.nytimes.com/2012/06/03/health/painkillers-add-costs- and-delays-toworkplace-injuries.html?pagewanted=all&-r=0. Accessed January 25, 2013.
6. Jensen MK, Thomsen AB, Hojsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur J Pain. 2006;10:423-433.
7. Brohnert T, Valenstein M, Bair M. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-1321.
8. Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686-691.
9. Heit HA, Gourlay DL. Buprenorphine: new tricks with an old molecule for pain management. Clin J Pain. 2008; 24:93-97.
10. Malinoff HL, Barkin RL, Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. 2005;12:379-384.
11. Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage. 2005;29:297-326.
12. Gibbons P, Christensen C, Malinoff H. Sedative dependence, detoxification and treatment. Abstract presented at: American Society of Addiction Medicine 38th Annual Medical-Scientific Conference; April 29, 2007; Miami FL.
13. Berland D, Rodgers P. Rational use of opioids for management of chronic nonterminal pain. Am Fam Physician. 2012;86:252-258.
14. Fitzcharles MA, Ste-Marie PA, Gamsa A, et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med. 2011;124:955-960.
15. Braden JB, Russo J, Fan MY, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010;170:1425-1432.
16. Craig TK, Drake H, Mills K, et al. The South London Somatisation Study. II. Influence of stressful life events, and secondary gain. Br J Psychiatry. 1994;165:248-258.
17. Craig TK, Boardman AP, Mills K, et al. The South London Somatisation Study. I: longitudinal course and the influence of early life experiences. Br J Psychiatry. 1993;163:579-588.
18. MacMillan H. The sequelae of child maltreatment. Curr Opin Psychiatry. 2001;14:325-331.
19. Brookoff D. Chronic pain: 1. A new disease? Hosp Pract (Minneap). 2000;35:45-52, 59.
20. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006;7:43-48.
21. Bekhit MH. Opioid-induced hyperalgesia and tolerance. Am J Ther. 2010;17:498-510.
22. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24:479-496.
23. Nilsen HK. Patients with problematic opioid use can be weaned from codeine without pain escalation. Acta Anaesthesiol Scand. 2010;54:571-579.
24. Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag. 2006;2:277-282.
25. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570-587.